Immuron LimitedASX: IMC

US DoD Travelan Clinical Update

· Issued by Immuron Limited

Filed with ASX · · 2 pages · English

Key Points • Manufacture of investigational medical products to support the Uniformed Services University (USU)clinical programto evaluate the efficacy of Travelan® and two other non- antibiotic OTC products inTravelers’Diarrheainitiated • USU are anticipating an enrolment start date of April 2022 and plan to enrol 1336 participants in total Melbourne, Australia, November 15, 2021: Immuron Limited

Immuron Limited on 6ix

Earlier from Immuron

Later from Immuron

All Immuron news releases